Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by eric_julien
Group name EquipeEJ
Item Type Journal Article
Title Histone H4K20 methylation mediated chromatin compaction threshold ensures genome integrity by limiting DNA replication licensing
Creator Shoaib et al.
Author Muhammad Shoaib
Author David Walter
Author Peter J. Gillespie
Author Fanny Izard
Author Birthe Fahrenkrog
Author David Lleres
Author Mads Lerdrup
Author Jens Vilstrup Johansen
Author Klaus Hansen
Author Eric Julien
Author J. Julian Blow
Author Claus S. Sřrensen
Abstract The decompaction and re-establishment of chromatin organization immediately after mitosis is essential for genome regulation. Mechanisms underlying chromatin structure control in daughter cells are not fully understood. Here we show that a chromatin compaction threshold in cells exiting mitosis ensures genome integrity by limiting replication licensing in G1 phase. Upon mitotic exit, chromatin relaxation is controlled by SET8-dependent methylation of histone H4 on lysine 20. In the absence of either SET8 or H4K20 residue, substantial genome-wide chromatin decompaction occurs allowing excessive loading of the origin recognition complex (ORC) in the daughter cells. ORC overloading stimulates aberrant recruitment of the MCM2-7 complex that promotes single-stranded DNA formation and DNA damage. Restoring chromatin compaction restrains excess replication licensing and loss of genome integrity. Our findings identify a cell cycle-specific mechanism whereby fine-tuned chromatin relaxation suppresses excessive detrimental replication licensing and maintains genome integrity at the cellular transition from mitosis to G1 phase.
Publication Nature Communications
Volume 9
Issue 1
Pages 3704
Date Sep 12, 2018
Journal Abbr Nat Commun
Language eng
DOI 10.1038/s41467-018-06066-8
ISSN 2041-1723
Library Catalog PubMed
Extra PMID: 30209253 PMCID: PMC6135857
Tags epigenmed, ligue, original
Date Added 2018/09/26 - 15:46:20
Date Modified 2019/11/29 - 16:50:51


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés